Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald E Mager

Showing results (11-20 of 163) with videos related to

Pageof 17
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|September 23, 2015
Physiologically-based pharmacokinetic modeling of target-mediated drug disposition of bortezomib in miceLi Zhang, Donald E Mager
Journal of Pharmaceutical Sciences|March 30, 2016
Calculated Log D Is Inversely Correlated With Select Camptothecin Clearance and Efficacy in Colon Cancer XenograftsCharvi Nanavati, Donald E Mager
The Journal of Pharmacology and Experimental Therapeutics|April 11, 2018
Network-Based Analysis of Bortezomib Pharmacodynamic Heterogeneity in Multiple Myeloma CellsVidya Ramakrishnan, Donald E Mager
CPT: Pharmacometrics & Systems Pharmacology|December 6, 2018
Pharmacodynamic Models of Differential Bortezomib Signaling Across Several Cell Lines of Multiple MyelomaVidya Ramakrishnan, Donald E Mager
Pharmaceutical Research|September 24, 2005
Quasi-equilibrium pharmacokinetic model for drugs exhibiting target-mediated drug dispositionDonald E Mager, Wojciech Krzyzanski
Journal of Pharmaceutical Sciences|November 26, 2018
Systems Modeling of Bortezomib and Dexamethasone Combinatorial Effects on Bone Homeostasis in Multiple Myeloma PatientsLi Zhang, Donald E Mager
Pharmaceutical Research|January 20, 2017
Sequential Exposure of Bortezomib and Vorinostat is Synergistic in Multiple Myeloma CellsCharvi Nanavati, Donald E Mager
The AAPS Journal|August 17, 2021
Network-Based Systems Analysis Explains Sequence-Dependent Synergism of Bortezomib and Vorinostat in Multiple MyelomaCharvi Nanavati, Donald E Mager
Journal of Clinical Pharmacology|October 1, 2010
Bridging pharmacology and pathophysiology via systems modelingDavid Z D'Argenio, Donald E Mager
Journal of Pharmacokinetics and Pharmacodynamics|October 25, 2016
Array of translational systems pharmacodynamic models of anti-cancer drugsSihem Ait-Oudhia, Donald E Mager
Pageof 17

Showing results (11-20 of 163) with videos related to

Sort By:
Pageof 17
Journal of Pharmacokinetics and Pharmacodynamics|September 23, 2015
Physiologically-based pharmacokinetic modeling of target-mediated drug disposition of bortezomib in miceLi Zhang, Donald E Mager
Journal of Pharmaceutical Sciences|March 30, 2016
Calculated Log D Is Inversely Correlated With Select Camptothecin Clearance and Efficacy in Colon Cancer XenograftsCharvi Nanavati, Donald E Mager
The Journal of Pharmacology and Experimental Therapeutics|April 11, 2018
Network-Based Analysis of Bortezomib Pharmacodynamic Heterogeneity in Multiple Myeloma CellsVidya Ramakrishnan, Donald E Mager
CPT: Pharmacometrics & Systems Pharmacology|December 6, 2018
Pharmacodynamic Models of Differential Bortezomib Signaling Across Several Cell Lines of Multiple MyelomaVidya Ramakrishnan, Donald E Mager
Pharmaceutical Research|September 24, 2005
Quasi-equilibrium pharmacokinetic model for drugs exhibiting target-mediated drug dispositionDonald E Mager, Wojciech Krzyzanski
Journal of Pharmaceutical Sciences|November 26, 2018
Systems Modeling of Bortezomib and Dexamethasone Combinatorial Effects on Bone Homeostasis in Multiple Myeloma PatientsLi Zhang, Donald E Mager
Pharmaceutical Research|January 20, 2017
Sequential Exposure of Bortezomib and Vorinostat is Synergistic in Multiple Myeloma CellsCharvi Nanavati, Donald E Mager
The AAPS Journal|August 17, 2021
Network-Based Systems Analysis Explains Sequence-Dependent Synergism of Bortezomib and Vorinostat in Multiple MyelomaCharvi Nanavati, Donald E Mager
Journal of Clinical Pharmacology|October 1, 2010
Bridging pharmacology and pathophysiology via systems modelingDavid Z D'Argenio, Donald E Mager
Journal of Pharmacokinetics and Pharmacodynamics|October 25, 2016
Array of translational systems pharmacodynamic models of anti-cancer drugsSihem Ait-Oudhia, Donald E Mager
Pageof 17